Bausch + Lomb Launches Orphia AI Digital Health Platform for Eye Care
Advertisement
The technology is built on a proprietary large language model trained using more than 200 million real patient interactions and validated by over 7,500 licensed clinicians in the United States.
US-based global eye health organization Bausch + Lomb has launched Orphia, a new AI-powered digital health platform designed to help ophthalmologists spend more time with patients by streamlining routine workflows.
The platform has debuted with an AI-driven cataract education solution that prepares patients before surgery and lays the foundation for broader digital health capabilities throughout the eye care journey.
"We've invested deeply in developing better products, better molecules and better devices, and that work has advanced patient care. But one question has remained largely unanswered: How can we help physicians spend less time on everything around care and more time delivering it?" said Brent Saunders, Chairman and CEO, Bausch + Lomb.
Orphia will operate under Bausch + Lomb's newly established Digital Health Services division and has been built as a brand-agnostic platform, allowing it to support eye care providers regardless of the products, devices or treatments they use.
Rather than replacing existing clinical systems, the platform has been designed to integrate with them, generating actionable insights while fitting into established practice workflows.
Its first application focuses on pre-surgery cataract education. Through conversational AI, patients receive information about their condition, treatment options and common concerns before meeting their surgeon.
The objective is to ensure patients arrive better informed, making consultations more productive and allowing physicians to dedicate more attention to clinical decision-making instead of routine explanations.
To develop its conversational patient engagement capabilities, Bausch + Lomb has partnered with Hippocratic AI, a company specialising in voice AI agents for healthcare and life sciences.
The technology is built on a proprietary large language model trained using more than 200 million real patient interactions and validated by over 7,500 licensed clinicians in the United States.
The company says the platform is already deployed across several major healthcare organisations.
The company plans to gradually expand Orphia beyond cataract education to support additional stages of the patient journey, including care coordination, practice workflow optimisation and other operational processes intended to reduce administrative workload.
The platform will be led by Manisha Narasimhan, President of Digital Health Services at Bausch + Lomb, as the company expands its focus from traditional eye care products to AI-enabled digital health solutions.
Stay tuned for more such updates on Digital Health News
